Bromazepam has never been marketed in the United States, even though it is a widely prescribed anti-anxiety medication in dozens of other countries. The most likely reason is straightforward: its manufacturer, Roche, never pursued FDA approval for the US market, where several similar benzodiazepines were already established. Despite clinical trials showing it works well for anxiety, the drug remains absent from American pharmacies for commercial and regulatory reasons rather than safety concerns.
Why Roche Never Brought It to the US
Bromazepam was developed by the Swiss pharmaceutical company Hoffmann-La Roche, which also brought diazepam (Valium) to market. By the time bromazepam was being studied in the early 1980s, the US already had multiple FDA-approved benzodiazepines for anxiety: alprazolam (Xanax), lorazepam (Ativan), diazepam, chlordiazepoxide, oxazepam, and clorazepate. Getting a new drug through the FDA approval process costs hundreds of millions of dollars, and Roche would have been competing against its own products and against well-established generics.
There is no public record of Roche ever submitting a New Drug Application for bromazepam to the FDA. The company appears to have made a business decision that the US market didn’t justify the investment when it already had similar drugs approved there. This is not unusual in pharmaceuticals. Many effective, widely used medications in Europe, Canada, and elsewhere simply never go through the US approval process because a manufacturer decides the return isn’t worth the cost.
Where Bromazepam Is Available
Outside the US, bromazepam is one of the most commonly prescribed benzodiazepines in the world. Roche markets it under the brand names Lexotan, Lexotanil, Lexomil, and Lexatin depending on the country. According to European Medicines Agency records, it is authorized in France, Spain, Italy, Portugal, Belgium, Luxembourg, Denmark, Ireland, Malta, Iceland, Poland, Austria, Greece, Latvia, Lithuania, Estonia, Bulgaria, and Cyprus. It is also available in Canada (as Lectopam), Brazil, and many countries across Latin America, Asia, and Africa.
The drug comes in 1.5 mg, 3 mg, and 6 mg tablets, with a typical dose of 3 mg taken two or three times daily for anxiety. For severe cases in hospital settings, doses can go up to 6 to 12 mg two or three times daily, with a maximum of 60 mg per day.
How Bromazepam Compares to US Options
Bromazepam is a medium-potency benzodiazepine with a half-life of about 20 hours. In equivalency terms, 3 to 6 mg of bromazepam is roughly comparable to 0.5 to 1 mg of alprazolam or 5 to 10 mg of diazepam. It peaks in the bloodstream within one to four hours, which is slightly slower than alprazolam’s one to two hour window. Its 20-hour half-life places it between alprazolam (around 12 hours) and diazepam (up to 100 hours when you include its active breakdown products).
Pharmacologically, it does the same thing as other benzodiazepines: it enhances the calming chemical GABA in the brain, reducing anxiety, muscle tension, and agitation. Its side effect profile is also typical of the class. It carries the same risks of dependence, withdrawal symptoms (which can persist for weeks to over 12 months after stopping), and dangerous interactions with opioids that can slow breathing to life-threatening levels. There is nothing about bromazepam’s safety profile that sets it apart as more or less dangerous than the benzodiazepines already approved in the US.
Its Legal Status in the US
Here’s where it gets interesting: bromazepam does have a legal classification in the United States. The DEA lists it as a Schedule IV controlled substance, the same category as alprazolam, lorazepam, and diazepam. This means the US government recognizes it as a real drug with medical potential and moderate abuse risk, but no pharmaceutical company has an FDA-approved product to sell.
In practical terms, no US doctor can prescribe bromazepam because there is no FDA-approved formulation available at American pharmacies. A prescription requires a product that has gone through the approval process, and that simply doesn’t exist for bromazepam in the US.
Can You Bring It Into the US From Another Country?
If you’ve been prescribed bromazepam while living or traveling abroad, the rules for bringing it back are strict. US Customs and Border Protection states that only medications legally prescribable in the United States may be imported for personal use. Since bromazepam is not FDA-approved, this creates a gray area.
However, CBP does allow US residents to bring in controlled substances (other than narcotics like marijuana, cocaine, or heroin) at international land borders under specific conditions. Without a prescription from a US-licensed, DEA-registered doctor, you may not import more than 50 dosage units. With such a prescription, larger quantities are allowed, though getting a US doctor to write a prescription for a non-approved drug is essentially impossible through normal channels. You must declare the medication to customs, carry it in its original container, and have documentation from a physician explaining that it is medically necessary.
Ordering bromazepam from online pharmacies outside the US and having it shipped in is illegal in most cases. CBP is clear that importing drugs from outside the United States for personal use is generally prohibited, and controlled substances face additional scrutiny.
US Alternatives for Anxiety
If you’ve used bromazepam abroad and are looking for a similar option in the US, the closest equivalents by pharmacological profile are the FDA-approved benzodiazepines for anxiety disorders:
- Alprazolam (Xanax): Approved for generalized anxiety and panic disorder. Shorter-acting than bromazepam, with a 12-hour half-life.
- Lorazepam (Ativan): Approved for anxiety disorders. Similar intermediate duration of action.
- Oxazepam: Approved for anxiety disorders and alcohol withdrawal. Slower onset, which may mean less abuse potential.
- Clorazepate: Approved for short-term anxiety management. Longer-acting.
- Clonazepam (Klonopin): Approved for panic disorder. Longer half-life, often used when sustained coverage is needed.
A US doctor familiar with benzodiazepine equivalencies can help identify which approved medication most closely matches your previous bromazepam dose and duration of effect. The 20-hour half-life of bromazepam, combined with its moderate potency, makes lorazepam or clonazepam the closest functional matches depending on whether you need shorter or longer coverage throughout the day.